Pharmaceutical Equipment - Continued prosperous development, biologics market expansion brings important drivers
China's pharmaceutical equipment industry to continue the prosperous development of the rapid growth of the market size. According to the National Bureau of Statistics, the size of China's pharmaceutical equipment market size in 2020 is about 20 billion RMB. According to the financial data of several core companies in the market in the first three quarters of 2021, we expect that the market size of China's pharmaceutical equipment in 2021 may reach more than 25 billion RMB, a year-on-year growth of 25% +. Among them, the fastest growing is the bioengineering segment, we expect this segment market size may reach 6~8 billion RMB.

The rapid development of the biologics market has brought significant incremental growth to the pharmaceutical equipment market. According to Frost & Sullivan, China's biologics market is expected to reach RMB 1.3 trillion by 2030, with a CAGR of about 13% from 2020 to 2030. With the rapid development of China's biopharmaceutical and other sub-sectors, pharmaceutical companies will accelerate the expansion of production in order to enhance market competitiveness, which will become an important driving force for the development of the pharmaceutical equipment market.
Looking for chemical products? Let suppliers reach out to you!
2026-05-21
-
Life Science Ingredients Industry Overview
This issue offers a deep exploration of the evolving pharmaceutical and nutrition landscape, combining data, analysis, and insight to reveal key industry shifts and emerging directions. Support online permanent download.Published in: Nov. 2025
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
CPHI China 2023 | At the Heart of Pharma
-
The Use Of Gas Chromatography In Pharmaceutical Industry
-
Lianhua Qingwen's Road to Internationalization is Getting Wider and Wider
-
The New Crown Antigen Self-Testing Products Were Approved For Marketing Who Can Self-Test?
-
The 15 Most Valuable Brands in the 2021 China Pharmaceutical Brand Value List
-
From the collective departure of Pfizer executives to see the impact of national collection on generic drug companies
-
Policy escalation to impact China's antibiotics market
-
Analysis of China's chemical API market prospects
-
Over 200 companies in the pharmaceutical industry performed well in 3Q
-
Chinese drug companies help secure global drug supply
Recommend Reading
-
Lilly Bets Bigger on China
-
Rising API Costs Threaten Drug Prices
-
Novo Nordisk Faces a Compliance Test
-
BioNTech’s Founders Turn the Page
-
India’s API Trade Balance Turns Positive
-
Potassium Sorbate in Food: Safety, Uses, and Alternatives
-
This Week's Sodium Metabisulfite Prices Remain Stable (1.12-1.16) in China
-
DMF Market Mostly Stabilized, Downstream Demand Lacks
-
January Ethylene Glycol Stabilizes and Stops Falling, Enters Range-bound Oscillation
-
Steel in the Hourglass: Germany’s “Protect-Steel” Proposal and the Green Calculation Behind It